Your browser doesn't support javascript.
loading
Cancer risk-reducing surgery: Brazilian Society of Surgical Oncology Guideline Part 2 (Gastrointestinal and thyroid).
Carneiro, Vandré C G; Gifoni, Ana C L V C; Rossi, Benedito M; da Cunha Andrade, Carlos E M; de Lima, Fernanda T; de Campos Reis Galvão, Henrique; da Rocha, Jose C C; da Silva Barreto, Leonardo S; Ashton-Prolla, Patrícia; Guindalini, Rodrigo S C; de Farias, Terence P; Andrade, Wesley P; de Sousa Fernandes, Paulo H; Ribeiro, Reitan; Lopes, Andre; Tsunoda, Audrey T; Azevedo, Bruno R B; Marins, Carlos A M; de Albuquerque Oliveira Uchôa, Diego N; Dos Santos, Evandro A S; Coimbra, Felipe J F; Filho, Francisco A D; de Oliveira Lopes, Francisco C; Fernandes, Francisco G; Ritt, Guilherme F; Laporte, Gustavo A; Guimaraes, Gustavo C; Feitosa E Castro Neto, Heládio; Dos Santos, Jocela C; de Carvalho Vilela, Jordana B; Junior, Jorge G M; da Cunha, Juliano R; Milhomem, Leonardo M; da Silva, Luciana M; de Freitas Maciel, Luiza; Ramalho, Nathalia M; Nunes, Rafael L; de Araújo, Rodrigo G; de Assunção Ehrhardt, Rogério; Bocanegra, Ronald E D; Junior, Tyrone C S; de Oliveira, Viviane R; Surimã, Walyson S; de Melo Melquiades, Miriam; de Castro Ribeiro, Heber S; Oliveira, Alexandre F.
Afiliação
  • Carneiro VCG; Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.
  • Gifoni ACLVC; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil.
  • Rossi BM; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • da Cunha Andrade CEM; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • de Lima FT; Oncogenetic, Surgical Oncology, Hospital Sírio Libanês, São Paulo, Brazil.
  • de Campos Reis Galvão H; Department of Oncogynecology, Barretos Cancer Hospital, Barretos, Brazil.
  • da Rocha JCC; Department of Oncogenetic, Hospital Israelita Albert Einstein, São Paulo, Brazil.
  • da Silva Barreto LS; Department of Oncogenetic, UNIFESP-EPM, São Paulo, Brazil.
  • Ashton-Prolla P; Department of Oncogenetic, DASA, São Paulo, Brazil.
  • Guindalini RSC; Department of Oncogenetic, Abdominal Surgery, A.C. Camargo Cancer, São Paulo, Brazil.
  • de Farias TP; Department of Surgery, HUOL/UFRN, Natal, Brazil.
  • Andrade WP; Department of Genetic, Hospital de Clínicas de Porto Alegre/UFRGS, Porto Alegre, Brazil.
  • de Sousa Fernandes PH; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
  • Ribeiro R; Department of Head and neck, oncological surgery, INCA, Rio de Janeiro, Brazil.
  • Lopes A; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil.
  • Tsunoda AT; Department of Surgery, Hospital Oswaldo Cruz, São Paulo, Brazil.
  • Azevedo BRB; Department of Surgery, Hospital Santa Catarina, São Paulo, Brazil.
  • Marins CAM; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil.
  • de Albuquerque Oliveira Uchôa DN; Department of Surgical oncology, Hospital Erasto Gaertner, Curitiba, Brazil.
  • Dos Santos EAS; Department of Surgical Oncology, São Camilo Oncologia, São Paulo, Brazil.
  • Coimbra FJF; Department of Surgical oncology, Hospital Erasto Gaertner, Curitiba, Brazil.
  • Filho FAD; Department of Surgery, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil.
  • de Oliveira Lopes FC; surgical oncology, Oncoclínicas, Curitiba, Brazil.
  • Fernandes FG; Department of Surgery, Pilar Hospital, Curitiba, Brazil.
  • Ritt GF; Department of Head and neck, oncological surgery, INCA, Rio de Janeiro, Brazil.
  • Laporte GA; Department of Surgery, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil.
  • Guimaraes GC; Department of Surgery, Hospital Universitário Professor Alberto Antunes - UFAL, Maceió, Brazil.
  • Feitosa E Castro Neto H; Department of Surgery, IMERV, Ribeirão Preto, Brazil.
  • Dos Santos JC; Department of Oncogenetic, Abdominal Surgery, A.C. Camargo Cancer, São Paulo, Brazil.
  • de Carvalho Vilela JB; Department of Surgery, Hospital Regional de Cacoal, Cacoal, Brazil.
  • Junior JGM; Department of Surgery, Hospital do Coração de Londrina, Londrina, Brazil.
  • da Cunha JR; Department of Surgical oncology, Hospital do Câncer - UOPECCAN, Cascavel, Brazil.
  • Milhomem LM; Department of Surgery, AMO/OSID, Salvador, Brazil.
  • da Silva LM; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
  • de Freitas Maciel L; Department of Surgery, Hospital Beneficência Portuguesa, São Paulo, Brazil.
  • Ramalho NM; Department of Surgical Oncology, Instituto do Câncer do Ceará, Fortaleza, Brazil.
  • Nunes RL; Department of Surgery, HUPAA/UFAL, Maceió, Brazil.
  • de Araújo RG; Department of Surgical oncology, Hospital do Câncer Araújo Jorge, Goiânia, Brazil.
  • de Assunção Ehrhardt R; Department of Surgery, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil.
  • Bocanegra RED; Department of Surgery, Hospital Santa Rita, Porto Alegre, Brazil.
  • Junior TCS; Department of Surgery, Universidade Federal de Uberlândia, Uberlândia, Brazil.
  • de Oliveira VR; Department of Surgery, Hospital das Clínicas da Universidade Federal de Goiás, Goiânia, Brazil.
  • Surimã WS; Department of Pelvic Surgery, Hereditary Cancer Program, Hospital de Câncer de Pernambuco, Recife, Brazil.
  • de Melo Melquiades M; Department of Head and neck, oncological surgery, INCA, Rio de Janeiro, Brazil.
  • de Castro Ribeiro HS; Surgey, Gynecology, Oncology, Instituto de Medicina Integral Professor Fernando Figueira, Recife, Brazil.
  • Oliveira AF; Department of Oncogenetic, Oncology, Oncologia D'or, Rio de Janeiro, Brazil.
J Surg Oncol ; 126(1): 20-27, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35689578
ABSTRACT

BACKGROUND:

Risk-reducing operations are an important part of the management of hereditary predisposition to cancer. In selected cases, they can considerably reduce the morbidity and mortality associated with cancer in this population.

OBJECTIVES:

The Brazilian Society of Surgical Oncology (BSSO) developed this guideline to establish national benchmarks for cancer risk-reducing operations.

METHODS:

The guideline was prepared from May to December 2021 by a multidisciplinary team of experts to discuss the surgical management of cancer predisposition syndromes. Eleven questions were defined and assigned to expert groups that reviewed the literature and drafted preliminary recommendations. Following a review by the coordinators and a second review by all participants, the groups made final adjustments, classified the level of evidence, and voted on the recommendations.

RESULTS:

For all questions including risk-reducing colectomy, gastrectomy, and thyroidectomy, a major agreement was achieved by the participants, always using accessible alternatives.

CONCLUSION:

This and its accompanying article represent the first guideline in cancer risk reduction surgery developed by the BSSO and it should serve as an important reference for the management of families with cancer predisposition.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncologia Cirúrgica / Neoplasias Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Surg Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oncologia Cirúrgica / Neoplasias Tipo de estudo: Etiology_studies / Guideline / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Brasil Idioma: En Revista: J Surg Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Brasil